Clinical Trial Update: A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the long-term performance of the DePuy ASR hip resurfacing system from a single center; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Collagen Disorders
• Congenital Hip Dysplasia
• Nonunion of Femoral Fractures
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Slipped Capital Femoral Epiphysis

Drugs mentioned

• DePuy ASR Hip System

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED